Skip to the main content
LongevityGLP1
Question

Wegovy and your gallbladder: gallstones, inflammation and what to watch for

Gallbladder trouble is one of Wegovy's listed warnings. It's uncommon, but it shows up more often than on placebo, and the label says weight loss alone doesn't explain it. Here are the numbers by group, the four symptoms to know, and what the label does and doesn't say about people with no gallbladder.

Marisol Keane

How this page is paid for: Some links here are partner links. If you start care through one, the provider may pay LongevityGLP1 a fee, and your monthly price stays the same. How we make money

The short answer

Yes, Wegovy can raise the risk of gallbladder problems. In adult weight-loss trials, gallstones were reported in 1.6% of people on the injection and 0.7% on placebo, and gallbladder inflammation in 0.6% versus 0.2%. The label says the higher rate held even after accounting for weight lost. It doesn't address people without a gallbladder.

Key takeaways

  • Acute gallbladder disease is a listed warning on Wegovy's label.
  • Adults on the injection: gallstones 1.6% vs 0.7% on placebo; gallbladder inflammation 0.6% vs 0.2%. On the tablets, gallstones ran 2.5% vs 1%.
  • Teens 12 and older on the injection: gallstones 3.8% vs 0%; inflammation 0.8% vs 0%.
  • Fast weight loss raises gallstone risk on its own, but the label says Wegovy's excess held "even after accounting for the degree of weight loss."
  • The label doesn't address people who've had their gallbladder removed. That's a decision for your prescriber.

Your gallbladder is a small pouch under the liver that stores bile, the fluid that helps digest fat. Gallstones are hardened bits of that bile, and Wegovy's label lists acute gallbladder disease as one of its warnings, and the trial numbers show why [1]. The risk is small in absolute terms, but it's real, and the four symptoms below are worth knowing by heart. The drug behind Wegovy is covered in semaglutide.

Wegovy is linked to more gallstones than placebo

The label puts it directly: “Treatment with WEGOVY is associated with an increased occurrence of cholelithiasis and cholecystitis” [1]. Cholelithiasis means gallstones, and cholecystitis means an inflamed gallbladder.

In adult weight-loss trials of the injection, gallstones were reported by 1.6% of people on Wegovy and 0.7% on placebo. Inflammation was reported by 0.6% versus 0.2% [1]. Put another way, roughly 16 in 1,000 people on Wegovy reported gallstones, against 7 in 1,000 on placebo.

Gallstones reported in adult weight-loss trials of the Wegovy injection
Wegovy injection
1.6%[1]
Placebo
0.7%[1]
Gallbladder events in Wegovy trials (US label, June 2026)
Who was studiedGallstones (Wegovy vs placebo)Gallbladder inflammation (Wegovy vs placebo)
Adults, injection1.6% vs 0.7%0.6% vs 0.2%
Adults, tablets2.5% vs 1%Not stated separately
Ages 12 and older, injection3.8% vs 0%0.8% vs 0%

All figures from weight-reduction trials in the Wegovy prescribing information [1]. Each row is a different trial population, so compare within a row, not across rows.

Weight loss alone doesn't explain it, the label says

Losing weight quickly is a known risk for gallstones, whatever the method, so you might expect that to account for the whole difference. The label says it doesn't: “Substantial or rapid weight loss can increase the risk of cholelithiasis; however, the incidence of acute gallbladder disease was greater in WEGOVY-treated patients than in placebo-treated patients, even after accounting for the degree of weight loss” [1].

The patient counseling section repeats the point for patients: gallbladder disease “may also occur in the absence of substantial or rapid weight loss” [1]. So a slow, steady loss doesn't rule it out. The label doesn't explain why semaglutide has this effect, and this page doesn't guess.

Rates were higher in teens and on the tablets

Two groups stood out in the label's data. In the trial of children 12 and older, 3.8% on the Wegovy injection reported gallstones and none on placebo did; 0.8% reported inflammation, again against none [1]. The label notes the incidence “was higher in WEGOVY injection-treated pediatric patients aged 12 years and older than in WEGOVY injection-treated adults.”

Adults on the tablets reported gallstones at 2.5% versus 1% on placebo tablets [1]. The tablet trials were separate studies with their own populations, so the gap with the injection isn't a head-to-head result. The pill itself is covered in oral semaglutide.

Four symptoms can mean a gallbladder problem

Wegovy's Medication Guide tells patients: “WEGOVY may cause gallbladder problems including gallstones. Some gallbladder problems need surgery. Call your healthcare provider if you have any of the following symptoms” [1]. It lists four:

  • pain in your upper stomach (abdomen)
  • yellowing of skin or eyes (jaundice)
  • fever
  • clay-colored stools

Ordinary stomach upset is far more common on Wegovy than any of these, which can make it hard to tell the two apart. This table separates them using the label's own lists. It isn't a diagnosis, and anything severe, persistent or new deserves a call. You can also report side effects to FDA's MedWatch program [2].

Upset stomach or gallbladder?
SymptomMore typical ofWhat the label says to do
Queasy, mild nausea, more after a dose increaseOrdinary digestive side effectsTell your provider if it's severe or won't go away
Bloating, burping, gasOrdinary digestive side effectsTalk to your provider about any side effect that bothers you or doesn't go away
Pain in the upper stomachPossible gallbladder problemCall your healthcare provider
Fever with stomach painPossible gallbladder problemCall your healthcare provider
Yellow skin or eyes, or clay-colored stoolsPossible gallbladder problemCall your healthcare provider
Severe stomach pain that won't go away, sometimes felt in the backPossible pancreatitisStop Wegovy and call your healthcare provider right away

Wording follows the Wegovy Medication Guide [1]. How common the ordinary digestive effects are, and how long they last, is in Wegovy nausea and constipation.

Can you take Wegovy without a gallbladder? The label doesn't say

Wegovy's label doesn't address people who've had their gallbladder removed. Gallbladder removal isn't one of its contraindications, and there's no separate guidance for people without one [1]. Anything beyond that, whether reassurance or warning, would be a guess.

So this is a prescriber's call, made with your history in front of them. These questions are worth bringing to that visit:

  • Why was my gallbladder removed, and does that change anything for me on Wegovy?
  • Which symptoms should make me call you, given I don't have a gallbladder?
  • Do I have any history of pancreatitis or bile duct problems that matters here?

If gallstones are suspected, the label calls for tests and follow-up

The label's instruction to prescribers is short: “If cholelithiasis is suspected, gallbladder studies and appropriate clinical follow-up are indicated” [1]. The label doesn't say Wegovy must stop. That's decided case by case, with your prescriber.

Gallbladder disease sits alongside the label's other warnings, such as pancreatitis and kidney injury from dehydration. The whole list is in is Wegovy safe, and the full side-effect table is in Wegovy side effects.

Gallbladder warnings run across this drug class

Wegovy isn't alone here, since Zepbound's label carries a gallbladder warning too, with its own trial numbers, covered in Zepbound side effects. Trials of different drugs used different people and methods, so their rates can't be ranked against each other. If you're choosing between them, the brand page in Wegovy is a starting point for the conversation with your prescriber.

Compare before you sign up: 21 brand Wegovy and Zepbound self-pay programs, scored on price, care and pharmacy checks.

Providers that offer Wegovy

  • Maximus

    You want a brand GLP-1 pill such as Foundayo or Wegovy tablets at a printed cash price, from a provider that names its pharmacies.

    Maximus review →
  • AgelessRx

    You want a longevity-focused program for rapamycin or metformin with labs built in, or brand Wegovy pill access with a clear monthly total.

    AgelessRx review →
  • Ro

    You want an FDA-approved GLP-1, such as the Wegovy pill, Foundayo or Zepbound, at a published cash price for each dose, or help getting a pen covered by insurance.

    Ro review →
  • Heally

    You want to talk through off-label rapamycin or metformin with a physician in a live visit, with the medication and visit bundled at a printed monthly price.

    Heally review →
  • MEDGmPartner

    You want labs, clinician visits, side-effect medicine and shipping in one monthly price that holds at every dose, from a program that names its pharmacies.

    Visit site →

See all 21 providers on the brand Wegovy and Zepbound lineup →

Frequently asked

Does Wegovy cause gallbladder problems right away?
The label doesn't say when gallbladder problems tend to appear. It gives how often they happened over the trials, not a timeline.
Should I stop Wegovy if I have gallstones?
That's your prescriber's decision. The label calls for gallbladder studies and follow-up when gallstones are suspected. It doesn't set a rule that Wegovy must stop.
Can Wegovy cause pancreatitis too?
Pancreatitis is a separate warning on Wegovy's label. Its main sign is severe stomach pain that won't go away, sometimes felt in the back. The Medication Guide says to stop Wegovy and call your provider right away if that happens.
Is gallbladder removal common on Wegovy?
Wegovy's label doesn't give a gallbladder-removal rate. Its Medication Guide says some gallbladder problems need surgery, without a number attached.

Sources

  1. [1] Wegovy (semaglutide) injection and tablets, prescribing information and Medication Guide (version 19, June 2026) (2026). DailyMed label
  2. [2] MedWatch: The FDA Safety Information and Adverse Event Reporting Program (2026). FDA

Picked for the same drugs and questions as this page.